Keryx treatment gets faster FDA review
AP - Wed Dec 2, 3:42 pm ETKeryx Biopharmaceuticals Inc. and AEterna Zentaris Inc. said Wednesday the Food and Drug Administration granted the potential cancer treatment Perifosine a fast-track review process.
Food and Drug Administration
4724 Stories, most recent news story added 56 minutes ago
News Stories
-
Tired of Waiting, Teva Advances
The Motley Fool - Wed Dec 2, 3:48 pm ETWhen all else fails, just follow the established pathway to approval.
-
LI drugmaker gets OK to make generic psoriasis cream
Newsday - Wed Dec 2, 8:12 pm ETAn Amityville pharmaceutical manufacturer has obtained final federal approval to make a generic version of an ointment that treats a form of psoriasis.
-
Orphan Drug Status for BioMarin Drug
Zacks.com via Yahoo! Finance - Wed Dec 2, 11:16 am ETBioMarin receives FDA orphan drug status for 3,4-DAP.
-
KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet
redOrbit - Wed Dec 2, 8:09 pm ETST. LOUIS, Dec. 2 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) today announced that that it has entered into an employment agreement with Interim President and Chief Executive Officer David A. Van Vliet with a term through December 31, 2011. Mr.
-
Another Approval for LLY's Cymbalta
Zacks.com via Yahoo! Finance - Wed Dec 2, 11:06 am ETEli Lilly's Cymbalta received approval from the FDA for the maintenance treatment of generalized anxiety disorder in adults.
-
Biotech Stocks: Dyax, Santarus, CytRx soar; Hemispherx craters
Market Watch - Wed Dec 2, 10:40 am ETDyax's shares gain on news the biotech company has won regulatory approval for its drug to treat the rare disorder hereditary angioedema.
-
United Airlines, Regency Energy, Walgreen: U.S. Equity Preview
Bloomberg - Wed Dec 2, 10:01 am ETDec. 2 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading . Stock symbols are in parentheses, and prices are as of 9 a.m. in New York.
-
Javelin submits pain-relief drug candidate to FDA
Mass High Tech: The Journal of New England Technology - Wed Dec 2, 4:15 pm ETJavelin Pharmaceuticals, Inc. today announced that it has submitted its drug target for pain to the U.S. Food and Drug Administration for review. The product, Dyloject, is an IV non-steroidal anti-inflammatory drug (NSAID) target for the management of acute moderate-to-severe pain in adults.
-
JoS A. Bank, Regency Energy, Santarus, SWS: U.S. Equity Preview
Bloomberg - Wed Dec 2, 9:31 am ETDec. 2 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading . Stock symbols are in parentheses, and prices are as of 8:10 a.m. in New York.
-
South Bend doctor excited about test for ovarian cancer risk
South Bend Tribune - 56 minutes agoSOUTH BEND -- A local physician believes a recent breakthrough in ovarian cancer research could help predict which women are at a greater risk.
-
Premarket roundup: McDonald's, Santarus
AP via Yahoo! Finance - Wed Dec 2, 9:18 am ETAmong the premarket stories for Wednesday, Dec. 2, from AP Financial News: -- While the retirement of McDonald's Corp. President and Chief Operating Officer Ralph Alvarez is disappointing, the casual restaurant chain has a deep enough management team to continue to fare well after his departure, an analyst said.
-
Keryx treatment gets faster FDA review
Newsday - Wed Dec 2, 5:56 pm ETKeryx Biopharmaceuticals cancer drug candidate gets faster regulatory review by FDA
-
Class Lawyers Win $50 Million Over Hair-Loss Fix
Law.com - Wed Dec 2, 1:25 pm ETAn Alameda County, Calif., a jury late last month returned a $50 million verdict in a class action that sought relief for Californians who'd bought Avacor, a hair-loss remedy that was marketed as an all-natural, clinically tested product. The outcome against two defendants marked the second trial victory in the same class action for the plaintiff lawyers. The earlier trial had ended in a $40 ...
-
Dyax, RF Micro: Early Volume Plays
TheStreet.com - Wed Dec 2, 8:56 am ETSeveral stocks trading near $5 were poised to move on above-average volume during Wednesday's session
-
Movers & Shakers: Wednesday's biggest gaining and declining stocks
Market Watch - Wed Dec 2, 8:55 am ETCiena Corp., RF Micro Devices, Santarus and GameStop are among companies making notable moves in the U.S. market.
FDA: Recalls
-
Rikki USA, Inc.Re-Issues Allergy Alert on Undeclared Shrimp in Toi Sauce Thai Red Curry (Panang) produced for the Siamrica Co. to Correct Lot Number
Tue Dec 1, 3:52 pm EST -
Diamond Pet Foods Announces Recall of Premium Edge Adult Cat and Premium Edge Hairball Cat Food
Tue Dec 1, 10:11 am EST -
La Espiga De Oro, Inc. Issues Allergy Alert on Undeclared Whey in Flour Tortillas
Tue Dec 1, 8:57 am EST -
Stryker Corporation’s Instruments Division Issues Worldwide Class 1 Recall of 23 Operating Room System II Surgical Navigation Systems; Catalog numbers 7700-100-000 and 7700-101-201
Wed Nov 25, 3:10 pm EST -
Vita Food Products, Inc. Issues an Alert Announcing Undeclared Wheat in ELF Branded Herring in Sour Cream
Wed Nov 25, 12:44 pm EST
Most Blogged About
-
FAA will allow Boeing 777 aircraft with suspect parts to stay aloft
DailyFinance - Mon Nov 30, 5:10 am EST -
YEARS AGO, the FDA shut down sales of a product called Jogging In A Jug. “By law, the product–a mi…
Instapundit - Mon Nov 30, 1:34 pm EST -
BPA: The Tangled Web of Green
Big Government - Mon Nov 30, 11:57 pm EST
